Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
46.51
+0.23 (0.50%)
At close: Jan 16, 2026, 4:00 PM EST
46.21
-0.30 (-0.65%)
Pre-market: Jan 20, 2026, 4:23 AM EST
Vera Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$76.60
Upside
+64.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $48 → $66 | Strong Buy | Maintains | $48 → $66 | +41.90% | Dec 19, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $55 → $95 | Strong Buy | Maintains | $55 → $95 | +104.26% | Dec 19, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $99 → $96 | Buy | Maintains | $99 → $96 | +106.41% | Dec 19, 2025 |
| Wedbush | Wedbush | Hold Maintains $23 → $33 | Hold | Maintains | $23 → $33 | -29.05% | Dec 11, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $75 → $97 | Buy | Maintains | $75 → $97 | +108.56% | Dec 8, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $60 → $73 | Strong Buy | Maintains | $60 → $73 | +56.96% | Dec 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $85 → $90 | Strong Buy | Maintains | $85 → $90 | +93.51% | Nov 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $53 → $52 | Buy | Maintains | $53 → $52 | +11.80% | Nov 7, 2025 |
| B of A Securities | B of A Securities | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +3.20% | Oct 16, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $56 → $53 | Buy | Maintains | $56 → $53 | +13.95% | Aug 7, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 4, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $65 → $55 | Buy | Maintains | $65 → $55 | +18.25% | Jun 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 → $85 | Strong Buy | Maintains | $75 → $85 | +82.76% | Jun 2, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $60 → $55 | Buy | Maintains | $60 → $55 | +18.25% | May 12, 2025 |
| Wedbush | Wedbush | Hold Maintains $34 → $26 | Hold | Maintains | $34 → $26 | -44.10% | May 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $107 → $100 | Buy | Maintains | $107 → $100 | +115.01% | May 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.